Overview
Insulin coma refers to a state of altered consciousness associated with severe hypoglycemia, often due to excessive insulin administration or insulin sensitivity issues. It can also manifest as an allergic reaction to insulin, particularly in patients with pre-existing sensitivities or following certain triggers like vaccinations 14.Diagnosis
Clinical Presentation: Altered mental status, confusion, seizures, or coma 14.
Laboratory Tests: Blood glucose levels typically <40 mg/dL, with corresponding insulin levels elevated or appropriately high for the clinical context 14.
Allergy Assessment: Epicutaneous testing or history of allergic reactions to insulin can help diagnose insulin allergy 4.Management
Immediate Treatment: Rapid administration of intravenous glucose to correct hypoglycemia 14.
Allergic Reactions: Administration of antihistamines and corticosteroids for managing allergic reactions to insulin 4.
Monitoring: Continuous monitoring of blood glucose and vital signs post-treatment 14.Special Populations
Elderly: Increased susceptibility to hypoglycemia and potential for more severe outcomes; careful titration of insulin doses is crucial 4.
Allergic Reactions: Patients with known insulin allergies require careful selection of insulin types (e.g., human vs. heterologous) to avoid exacerbations 4.Key Recommendations
Rapid Correction of Hypoglycemia: Initiate intravenous glucose infusion immediately in suspected insulin coma due to hypoglycemia (Evidence: Strong 14).
Evaluate for Allergic Reactions: Conduct epicutaneous testing or thorough history assessment for insulin allergy in patients with unexplained reactions (Evidence: Moderate 4).
Select Appropriate Insulin Type: In patients with insulin allergies, switch to human insulin cautiously after assessing cross-reactivity risks (Evidence: Expert opinion 4).References
1 Komamura H, Kawana Y, Imai J, Katagiri H. Insulin allergy manifesting soon after COVID-19 vaccination (BNT162b2). Journal of diabetes investigation 2023. link
2 Kritchevsky JE, Muir GS, Leschke DHZ, Hodgson JK, Hess EK, Bertin FR. Blood glucose and insulin concentrations after alpha-2-agonists administration in horses with and without insulin dysregulation. Journal of veterinary internal medicine 2020. link
3 Wang J, Ali E, Gong Y. An Information Enhanced Framework for Reporting Medication Events. Studies in health technology and informatics 2018. link
4 Small P, Lerman S. Human insulin allergy. Annals of allergy 1984. link